1. Home
  2. PJT vs BLCO Comparison

PJT vs BLCO Comparison

Compare PJT & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PJT
  • BLCO
  • Stock Information
  • Founded
  • PJT 2014
  • BLCO 1853
  • Country
  • PJT United States
  • BLCO Canada
  • Employees
  • PJT N/A
  • BLCO N/A
  • Industry
  • PJT Investment Managers
  • BLCO Ophthalmic Goods
  • Sector
  • PJT Finance
  • BLCO Health Care
  • Exchange
  • PJT Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • PJT 4.4B
  • BLCO 5.2B
  • IPO Year
  • PJT N/A
  • BLCO 2022
  • Fundamental
  • Price
  • PJT $176.98
  • BLCO $15.67
  • Analyst Decision
  • PJT Hold
  • BLCO Hold
  • Analyst Count
  • PJT 3
  • BLCO 12
  • Target Price
  • PJT $192.50
  • BLCO $15.91
  • AVG Volume (30 Days)
  • PJT 192.0K
  • BLCO 502.0K
  • Earning Date
  • PJT 10-28-2025
  • BLCO 10-29-2025
  • Dividend Yield
  • PJT 0.57%
  • BLCO N/A
  • EPS Growth
  • PJT 54.67
  • BLCO N/A
  • EPS
  • PJT 5.83
  • BLCO N/A
  • Revenue
  • PJT $1,537,018,000.00
  • BLCO $4,891,000,000.00
  • Revenue This Year
  • PJT $12.16
  • BLCO $8.29
  • Revenue Next Year
  • PJT $12.52
  • BLCO $5.82
  • P/E Ratio
  • PJT $30.21
  • BLCO N/A
  • Revenue Growth
  • PJT 18.48
  • BLCO 8.81
  • 52 Week Low
  • PJT $119.76
  • BLCO $10.45
  • 52 Week High
  • PJT $190.28
  • BLCO $20.94
  • Technical
  • Relative Strength Index (RSI)
  • PJT 48.91
  • BLCO 61.17
  • Support Level
  • PJT $173.75
  • BLCO $14.67
  • Resistance Level
  • PJT $180.85
  • BLCO $15.90
  • Average True Range (ATR)
  • PJT 3.80
  • BLCO 0.46
  • MACD
  • PJT 0.25
  • BLCO 0.08
  • Stochastic Oscillator
  • PJT 56.23
  • BLCO 89.23

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: